Aridis Pharmaceuticals, Inc.·4

May 13, 4:15 PM ET

Truong Vu 4

4 · Aridis Pharmaceuticals, Inc. · Filed May 13, 2021

Insider Transaction Report

Form 4
Period: 2021-05-12
Truong Vu
DirectorCEO, CSO, Director10% Owner
Transactions
  • Award

    Stock Options

    2021-05-12+53,340599,390 total
    Exercise: $6.25Exp: 2031-05-12Common Stock (53,340 underlying)
Footnotes (1)
  • [F1]The stock options vest in equal installments over 12 months, beginning on May 12, 2021.

Documents

1 file
  • 4
    a4.xmlPrimary

    4